肾脂肪肉瘤(附三例报告及文献复习)

本文报道三例肾脂肪肉瘤,并结合文献复习,讨论了其病理,临床表现、影像学特征、诊断和治疗。     

黑蔓不同部位微量元素的测定

为了了解吉林省长白县山区所产卫矛科雷公藤属植物黑蔓的药理作用,扩大它的药用部位和应用范围,我们从无机元素与中药药效有密切关系的角度出发,实验测出黑蔓含有Ba、Si、Cu、Fe、Zn、Sn、Co、Mn、Mg、Ca、Se等无机元素,本文重点对其中人体必需的微量元素Cu、Fe、Zn、Se作了定量分析。     

Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation.

Autopsy and imaging studies show that liver involvement is common in cystic fibrosis. However, complications of chronic liver disease including portal hypertension and variceal bleeding are infrequently encountered, and the degree to which variceal hemorrhage affects prognosis in cystic fibrosis is unclear. This uncertainty has lead to debate as to whether liver transplantation is indicated in these patients. We describe a case series of 18 patients and compare their survival with a control group of cystic fibrosis patients without liver disease. The median age at first bleed was 20.0 years (range 9.7-30.9). The median survival after first bleed was 8.4 years, compared to 13.0 years in the control group (P = 0.15). A total of 14 patients have died, 9 from respiratory disease with no discernable contribution from their liver disease. Liver disease contributed to 4 deaths. Only 1 patient suffered a fatal hemorrhage, which may have been either variceal or bronchial in origin. Long-term survival is a frequent occurrence in patients with cystic fibrosis who suffer variceal hemorrhage, and age at death is comparable to the general cystic fibrosis population. In conclusion, this suggests that liver transplantation is not indicated in these patients without additional features of liver decompensation.     

加巴喷丁治疗癫痫的疗效及安全性研究

目的：加巴喷丁抗癫痫作用的有效性与安全性。方法：随机双盲，添加治疗安慰剂对照临床试验。整个试验历时6个月，入选者随机分入试验组或对照组，于试验前、入组后第1、4、8、12、16、20、24周末随访。结果：均衡性：加巴喷丁治疗癫痫在随访中均衡性较好，各指标间无明显差别。疗效评价：加巴喷丁添加治疗组结果显示较安慰剂组发作次数明显减少，两组间有统计学差别；对各类型癫痫总的治疗有效率及MMSE评分等方面无统计学差异，未显示出疗效；但对全身性强直阵挛发作类型具有明显疗效，具有统计学意义。安全性评价：加巴喷丁组和安慰剂组都有不良事件发生，加巴喷丁组居多，但差别无统计学意义。结论：加巴喷丁对全身性强直阵挛发作类型有效，对其它类型疗效不佳，是一种安全性较好的药物。     

浅析病案缺陷及其防范措施

在新形势下,全国各地实行了医疗、保险制度的改革.规范病案管理,提高病案的管理质量显得更为重要.如何使病案管理更科学、更规范,使病案管理在法律的监督下制度更健全;如何减少病案缺陷的出现,防止医疗纠纷的发生,是医院面临的新课题.     

从疾病构成比谈医院发展

医院住院病人疾病构成比,是从量上显示在特定范围内的某一疾病的患病比重,是一个不可忽视的统计指标,能了解医疗需求变化趋势,为医院床位、人员的配备、拟就工作规划及调整医院服务工作等方面提供重要信息,是医院管理工作的重要指标.本文就我院近五年的住院疾病构成作一个简要分析.     

胸部螺旋CT最大密度投影重建的参数优化

目的探讨胸部螺旋CT最大密度投影(MIP)重建合理的扫描和重建参数。方法6例煤工的尸检离体肺脏制成充气固定肺标本,分别行不同参数组合的螺旋CT扫描,包括层厚1.5mm,2mm,4mm及8mm,重建间隔1mm,3mm,5mm;曝光量150mA,100mA;螺距1.5;滤过算法包括标准、锐利和平滑3种。每组图像均行MIP重建,重建厚度为12.5mm～13mm,比较不同参数MIP重建图像对支气管血管束的显示。结果a)曝光量对MIP重建图像的影响甚微,150mA、100mA两组剂量MIP无显著性差异(P>0.05);b)重建算法对MIP重建无显著影响。c)扫描层厚影响MIP图像,以薄层(1.5mm)扫描重建为最佳,1.5mm、2mm、4mm层厚MIP图像之间无显著性差异(P>0.05),8mm层厚与前4者MIP图像有显著性差异(P<0.01)。d)重建间隔影响MIP重建效果,8mm层厚扫描,1mm和5mm重建间隔重建图像MIP之间有显著性差异(P<0.05)。结论影响MIP重建的参数主要为扫描层厚和重建间隔,薄层扫描可获得理想的MIP图像,随层厚的增加,减小重建间隔有利于获得理想的MIP图像。建议以中等层厚(4mm)扫描,小重建间隔(1.5mm,2mm)行MIP重建。     

Agilent 2100 Bioanalyzer在人乳头瘤病毒检测中的应用

目的：探讨Agilent2100Bioanalyzer芯片分析系统（简称Bioanalyzer)在人乳头瘤病毒（HPV）的PCR检测和分组中的应用。方法：先分别进行通用引物介导PCR（GP－PCR）和型特异性引物介导PCR，扩增HPV高保守区（L1区）的共同序列和各型（包括HPV6，11，16和18型）的特型性序列，然后分别用常规的琼脂糖凝胶电泳技术和Bioanalyzer对PCR产物进行检测，并比较两种检测方法的准确度，重复性和灵敏度。结果：Bioanalyzer在确定片段长度时的准确度和重复性比琼脂糖凝胶电泳高，前者的准确度在95％以上，后者仅为85％，Bioanalyzer的检测灵敏度比琼脂糖凝胶电泳高100倍，结论：Bioanalyzer芯片分析系统结合PCR方法可对HPV进行特异，准确，稳定，灵敏的检测和型别鉴定，具有重要的推广价值。     

Comparison of Minimum Alveolar Concentration between Intravenous Isoflurane Lipid Emulsion and Inhaled Isoflurane in Dogs

Background: As in inhaled isoflurane anesthesia, when isoflurane lipid emulsion (ILE; 8%, vol/vol) is intravenously administered, the primary elimination route is through the lungs. This study was designed to determine the minimum alveolar concentration (MAC) and the time course of washout of isoflurane for intravenously infused ILE by monitoring end-tidal isoflurane concentration.

Methods: Twelve healthy adult mongrel dogs were assigned randomly to an intravenous anesthesia group with 8% ILE or to an inhalation anesthesia group with isoflurane vapor. An up-and-down method and stimulation of tail clamping were used to determine MAC of 8% ILE by intravenous injection in the intravenous anesthesia group and MAC by the inhaled approach in the inhalation anesthesia group, respectively. Isoflurane concentration and partial pressure in end-tidal gas, femoral arterial blood, and jugular venous blood were measured simultaneously just before each tail clamping and during washout.

Results: The induction time in the intravenous anesthesia group (105 +/- 24 s) was shorter than that in the inhalation anesthesia group (378 +/- 102 s; P < 0.01). MAC of 8% ILE by intravenous injection (1.12 +/- 0.18%) was significantly less than MAC by the inhaled approach (1.38 +/- 0.16%; P < 0.05). No significant difference was found between the two groups in the time course of washout of isoflurane.